Bacteriophage Therapy in Patients With Urinary Tract Infections

Stopped early · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Urinary Tract Infection Bacterial

In brief

This is a phase I/II trial designed to evaluate bacteriophage therapy in patients with urinary tract infections.

Key facts

Study ID

NCT04287478

Run by

Adaptive Phage Therapeutics, Inc.

People needed

1

Starts

2020-12-09

Expected to finish

2023-02-28

Last updated by the study team

2023-03-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Universal Axon Clinical Research — Doral, Florida, United States
• AdMed Research — Miami, Florida, United States
• AMPM Research Clinic — Miami Gardens, Florida, United States
• Innovation Medical Research Center, Inc — Palmetto Bay, Florida, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• James J. Peters VA Medical Center — The Bronx, New York, United States
• University of Texas Southwestern Medical Center — Dallas, Texas, United States
• DHR Health Institute for Research and Development — Edinburg, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.